Category Archives: AZBio News

PhRMA Report: “Innovation in the Biopharmaceutical Pipeline: A Multi-Dimensional View”.

Posted on by

This morning PhRMA released a report, “Innovation in the Biopharmaceutical Pipeline: A Multi-Dimensional View”. The paper, by researchers at Analysis Group, examines the pipeline from several angles and helps to show the range of innovative research our companies are doing.

 

The reports find:

  • More than 5,000 medicines are in development globally
  • 70% of medicines in development are potentially first-in-class
  • Personalized medicines and drugs for rare diseases are rapidly growing parts of the drug development pipeline
  • Researchers are pursuing many new scientific approaches such as conjugated monoclonal antibodies and therapeutic cancer vaccines

Video streaming by Ustream
PhRMA’s  reports are part of their ongoing efforts to communicate the important contributions PhRMA companies are making to save and improve lives.

Resources

Report: Analysis Group Report

Report: Accompanying PhRMA Report

Release: Robust Biopharmaceutical Pipeline Offers New Hope for Patients

Related Press Coverage USA Today AP News

Related Blog Posts

Examining the Biopharmaceutical Pipeline – Webinar Jan 14, 2013

PhRMA Hosting Webinar Highlighting New Exciting Medicines in the Biopharmaceutical Pipeline January 11, 2013

 

Biocentury This Week: Computing for Cures

Posted on by

From Cold War computing on the West Coast to genome sequencing in Manhattan and FDA data mining in Washington, how advances in computer hardware and software promise to transform how drugs are discovered and developed.

The newest edition of BioCentury This Week television is joined by:

•

Dr.   Fred Streitz,   Director of the Institute for Scientific Computing Research at Lawrence   Livermore National Laboratory, who explains how high-performance computing is   being used to precisely simulate 370 million cells in the human heart.
•

Dr.   Eric Perakslis,   Chief Information Officer at FDA, on the agency’s progress in harnessing   mountains of clinical trial data.
•

Nancy   Kelley,   Executive Director and COO of the New York Genome Center, who describes the Big Apple’s ambitious efforts to merge medicine and information technology.

BioCentury 01.13.13 - [1] Extreme Levels
NOTICE:     BioCentury Publications, Inc., and WUSA-TV own the copyright to the program content  on “BioCentury This Week,” and except for limited use of these links to the  BioCenturytv.com website, BioCentury and WUSA prohibit hosting of BioCentury This Week program content by unauthorized third parties or posting of BioCentury  This Week content to any unauthorized third party websites such as YouTube. Other  BioCenturytv.com content and all trademarks   are the property of BioCentury or WUSA-TV or other third parties.

The Tomorrow Project Comes to Biodesign

Posted on by

 

Intel’s Tomorrow Project asks… What kind of future are you imagining? What kind of future do you want to live in? What future do you want to avoid?  

Through conversations about the future, can we make that future better?  The Tomorrow Project sets forth that “if we want to imagine a better future and then build it then we need to change the story we are telling ourselves about the future we want to live in.”

In the videos below, Intel Futurist Brian David Johnson visits with thought leaders at The Biodesign Institute at Arizona State University to explore the possibilities for shaping health, science and a better tomorrow…

(To learn more about The Tomorrow Project, Click Here.)

 

Biodesign, Biosignatures and Sensorbots with Deirdre Meldrum

Brian David Johnson talks to Deirdre Meldrum — ASU Senior Scientist, Director of the Center for Biosignatures Discovery Automation in the Biodesign Institute at ASU, and Professor of Electrical Engineering – about transforming healthcare by detecting diseases before any symptoms appear. For instance, detecting lung cancer before a CT image would.  Other topics include the development of Sensorbots monitoring biogeochemical processes in the ocean.

Biodesign, Science, and Stories of Possible Futures – a Conversation with Michael Birt

Intel futurist, Brian David Johnson talks with Michael Birt to contemplate a future in which people have a greater degree of personal control over predicting and preventing disease. Michael is the Director of the Center for Sustainable Health and Interim Co-director at Arizona State University’s Biodesign Institute – and author of a medical thriller set in Japan.